Cancer Letters
Volume 291, Issue 2 , Pages 230-236, 28 May 2010

Fhit loss in lung preneoplasia: Relation to DNA damage response checkpoint activation

  • Roberto Cirombella

      Affiliations

    • Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy
  • ,
  • Giuseppe Montrone

      Affiliations

    • Division of Pathology, Ospedale San Camillo Forlanini, Rome, Italy
  • ,
  • Antonella Stoppacciaro

      Affiliations

    • Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy
  • ,
  • Simona Giglio

      Affiliations

    • Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy
  • ,
  • Stefano Volinia

      Affiliations

    • Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, OH, USA
  • ,
  • Paolo Graziano

      Affiliations

    • Division of Pathology, Ospedale San Camillo Forlanini, Rome, Italy
  • ,
  • Kay Huebner

      Affiliations

    • Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, OH, USA
    • Corresponding Author InformationCorresponding authors. Addresses: Ohio State University Comprehensive Cancer Center, Biomedical Research Tower, Rm 916, 460W. 12th Ave., Columbus, OH 43210, USA. Tel.: +1 614 292 4850; fax: +1 614 688 8675 (K. Huebner). Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy (A. Vecchione).
  • ,
  • Andrea Vecchione

      Affiliations

    • Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy
    • Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, OH, USA
    • Corresponding Author InformationCorresponding authors. Addresses: Ohio State University Comprehensive Cancer Center, Biomedical Research Tower, Rm 916, 460W. 12th Ave., Columbus, OH 43210, USA. Tel.: +1 614 292 4850; fax: +1 614 688 8675 (K. Huebner). Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy (A. Vecchione).

Received 1 September 2009; received in revised form 21 October 2009; accepted 22 October 2009. published online 20 November 2009.

Abstract 

Loss of heterozygosity at the FHIT locus is coincident with activation of DNA damage response checkpoint proteins; thus damage at fragile loci may trigger checkpoint activation. We examined preneoplastic lesions adjacent to non-small cell lung carcinomas for alterations to expression of Fhit and activated checkpoint proteins. Expression scores were analyzed for pair-wise associations and correlations among proteins and type of lesion. Hyperplastic and dysplastic lesions were positive for nuclear γH2AX expression; 12/20 dysplastic lesions were negative for Fhit expression. Fhit positive lesions showed expression of most checkpoint proteins examined, while Fhit negative lesions showed absence of expression of Chk1 and phosphoChk1. The results show that loss of expression of Fhit is significantly directly correlated with absence of activated Chk1 in dysplasia, and suggest a connection between loss of Fhit and modulation of checkpoint activity.

Abbreviations: Fhit, fragile histidine triad protein, Wwox, WW-domain and oxidoreductase containing protein, γH2AX, gamma histone 2AX, ATM, ataxia telangiectasia gene, ATR, ataxia telangiectasia related gene, Chk1/2, checkpoint kinase proteins 1 and 2, 53BP1, p53 binding protein 1, NSCLC, non-small cell lung cancer, AAH, atypical adenomatous hyperplasia, DSBs, double-strand breaks, FISH, fluorescent in situ hybridization, LOH, loss of heterozygosity

Keywords: Fhit, Preneoplastic lesions of lung, DNA damage response checkpoint, Chromosome fragile sites, Squamous dysplasia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(09)00650-8

doi:10.1016/j.canlet.2009.10.017

Cancer Letters
Volume 291, Issue 2 , Pages 230-236, 28 May 2010